Closed Loop secures £2.1m funding
The funding will support the development of a drug and digital approach to treat and manage major health conditions.
13th May 2019
Latest news
NHS to tackle elderly over-medication with 200 new pharmacists
The recruits are part of a wider £20 million programme to reduce unnecessary medication of patients.
13th May 2019
NIHR launches new interactive costing tool
The tool aims to enable faster costing and contracting between the life sciences industry and the NHS.
13th May 2019
AZ, Forty Seven to test triple immunotherapy combo for lymphoma
5F9 will be tested in combination with rituximab and Calquence (acalabrutinib) for diffuse large B-cell lymphoma.
13th May 2019
‘Groundbreaking’ new brain cancer treatment available
The treatment is a part of the NHS Long Term Plan, which aims to save thousands more lives by catching more cancers early and starting treatment fast.
13th May 2019
£2m NHS investment into leadership development
The programme fits in with the NHS Long Term Plan, as it sets out to “nurture the next generation of NHS leaders".
10th May 2019
Potential first ever targeted therapy designed for ‘untreatable’ childhood brain cancer
The new drug class can kill brain cancer cells with mutations in the ACVR1 gene and shrink tumours in mice.
10th May 2019
Sanofi granted EU licensing for Dupixent
The approval marks the first biologic licensed in the EU for severe asthma with type II inflammation.
10th May 2019
World Lupus Day: new report reveals need for care improvements
Lupus affects 5 million patients worldwide, predominantly female.
10th May 2019
New report reveals priorities for local NHS research and innovation
Mental health and complex health issues among common themes that emerged from the consultation
9th May 2019
Gilead, Goldfinch to team up against kidney disease
The multi-year collaboration will expand the scope of Goldfinch’s proprietary Kidney Genome Atlas.
9th May 2019
AZ, Daiichi HER-2 drug shows promise in mid-stage trial
Approximately one in five breast cancers are HER2-positive, meaning there is an unmet need for treatments.
9th May 2019
Eisai, Dementia Research Institute join forces for research
The collaboration will draw together world-leading expertise into a single national institute that conducts research into all aspects of dementia including Alzheimer's disease.
9th May 2019
Ocrevus finally available on NHS
The availability of Ocrevus has been branded a “landmark moment” by the MS Society.
9th May 2019
Waylivra granted conditional marketing authorisation in Europe
The authorisation follows the positive opinion recommending approval provided by the Committee for Medicinal Products for Human Use (CHMP).
8th May 2019
